What is the price target for NEDAP stock?
8 analysts have analysed NEDAP.AS and the average price target is 92.82 EUR. This implies a price increase of 14.95% is expected in the next year compared to the current price of 80.75.
AMS:NEDAP • NL0000371243
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NEDAP N.V. (NEDAP.AS).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-07-17 | Berenberg | Maintains | Hold -> Hold |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 262.426M 14.36% | 251.606M -4.12% | 279.813M 11.21% | 311.06M 11.17% | 333.72M 7.28% | 356.38M 6.79% | 409.84M 15.00% | 430.65M 5.08% | 443.13M 2.90% | 456.65M 3.05% | 470.18M 2.96% | |
| EBITDA YoY % growth | 37.43M 12.70% | 34.911M -6.73% | 44.634M 27.85% | 47.895M 7.31% | 52.53M 9.68% | 57.68M 9.80% | 74.271M 28.76% | 81.969M 10.36% | 88.73M 8.25% | 91.435M 3.05% | 94.139M 2.96% | |
| EBIT YoY % growth | 27.323M 16.05% | 24.167M -11.55% | 32.311M 33.70% | 43.26M 33.89% | 48.41M 11.90% | 42.915M -11.35% | 61.165M 42.53% | 68.446M 11.90% | 74.895M 9.42% | 77.184M 3.06% | 79.576M 3.10% | |
| Operating Margin | 10.41% | 9.61% | 11.55% | 13.91% | 14.51% | 12.04% | 14.92% | 15.89% | 16.90% | 16.90% | 16.92% | |
| EPS YoY % growth | N/A 27.21% | N/A -21.65% | N/A 32.15% | 4.82 14.30% | 5.44 12.94% | 6.22 14.39% | N/A | N/A | N/A | N/A | N/A |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
8 analysts have analysed NEDAP.AS and the average price target is 92.82 EUR. This implies a price increase of 14.95% is expected in the next year compared to the current price of 80.75.
NEDAP N.V. (NEDAP.AS) will report earnings on 2026-04-07.
The consensus rating for NEDAP N.V. (NEDAP.AS) is 42.5 / 100 . This indicates that analysts generally have a neutral outlook on the stock.